IR-MED Inc. announced topline interim results from a clinical study of PressureSafe, a noninvasive handheld optical monitoring device that supports early detection of pressure injuries (PI) to the skin and underlying tissue. PressureSafe demonstrated very high efficacy in noninvasively detecting the presence and absence of pressure injuries below the skin's surface. These data confirm that PressureSafe can augment visual inspection with very high accuracy while bringing the added benefits of automated cloud-based digital storage of scan results, saving time and contributing to the healthcare provider's data-driven decision making.

Moreover, because PressureSafe is detecting biomarkers below the skin's surface, it can be more effective at sensing pressure injuries that are not yet visible to the human eye, leading to better outcomes for patients, especially those with darker skin tones. PressureSafe is a handheld device to support early detection of pressure injuries to the skin and underlying tissue, regardless of skin tone. $26.8 billion is spent each year to prevent and treat pressure injuries that result from long-term pressure on hard surfaces such as wheelchairs and beds.